Claya review
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
- Semaglutide
- $299/mo (compounded)
- Tirzepatide
- $299/mo (compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
Semaglutide · modeled / year
$3,588
Tirzepatide · modeled / year
$3,588
The Index scorecard
Claya scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
The tradeoffs
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
The bottom line
Best for: Cost-first shoppers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
Ranked #200 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Claya.
- #216TeleHealth Med— TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…62/100
- #217The Aesthetic Concierge— The Aesthetic Concierge is a physician-led US telehealth practice offering GLP-1 medical weight loss, led by co-founder and medical director Dr.62/100
- #218VyrarX— VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.62/100
- #219Alloy— Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide…61/100
- #220Aquivia Health— Aquivia Health is a clinician-led, self-pay telehealth platform offering compounded GLP-1 therapy with the option to step up to branded Ozempic or Zepbound — an unusual side-by-side most compounded…61/100
- #221boostAGErx— boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as…61/100
The 18 programs nearest this one
- #201 Contour Health62
- #202 DrMedHealth62
- #203 Framework62
- #204 Go Vida Plena62
- #205 Kina62
- #206 LevelsRx62
- #207 MyStart Health62
- #208 NativeMed62
- #209 NovoCare Pharmacy62
- #210 Open Water Rx62
- #211 Options Medical Weight Loss62
- #212 OurView Health62
- #213 ReadyRx62
- #214 Rejuve Meds62
- #215 RxPros62
- #222 Coivas61
- #223 GetRelief Rx61
- #224 LeanDose61
Pricing, states and verification reflect Claya's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.